Ranbaxy To Pull Out Of Some Small Markets To Focus On Profit Margins
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories is considering a pullback from some small markets offering low profit margins to concentrate on those, big and small, that promise at least 5%, sources said.